Paul Whitney
Chief Executive Officer at Parallel Private Equity LLP
Profile
Paul Michael Whitney currently works at Parallel Private Equity LLP, as Chief Executive Officer & Chairman from 1997.
Dr. Whitney also formerly worked at CIN Management Ltd., as Chief Executive Officer, Phytopharm Plc, as Chairman from 2006 to 2007, NatWest Equity Partners Ltd., as Chairman, Bridgepoint Capital (GP) Ltd., as Chairman, and 3i Plc, as Principal in 1983.
Dr. Whitney received his Masters Business Admin degree in 1980 from Cranfield University and undergraduate degree in 1972 and doctorate degree in 1972 from the University of Aston.
Paul Whitney active positions
| Companies | Position | Start |
|---|---|---|
Parallel Private Equity LLP
 Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | Chief Executive Officer | 01/01/1997 |
Former positions of Paul Whitney
| Companies | Position | End |
|---|---|---|
Phytopharm Plc
 Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | Chairman | 18/07/2007 |
| NatWest Equity Partners Ltd. | Chairman | - |
3i Plc
 3i Plc Financial ConglomeratesFinance 3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/1983 |
| Bridgepoint Capital (GP) Ltd. | Chairman | - |
CIN Management Ltd.
 CIN Management Ltd. Investment ManagersFinance Part of The Goldman Sachs Group, Inc., CIN Management Ltd. is a pension fund manager. The company is based in London, UK. CIN Management was acquired by Goldman Sachs Ltd. from British Coal Corp. on July 22, 1996 for $65 million. | Chief Executive Officer | - |
Training of Paul Whitney
| Cranfield University | Masters Business Admin |
| University of Aston | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | Health Technology |
| NatWest Equity Partners Ltd. | Finance |
CIN Management Ltd.
CIN Management Ltd. Investment ManagersFinance Part of The Goldman Sachs Group, Inc., CIN Management Ltd. is a pension fund manager. The company is based in London, UK. CIN Management was acquired by Goldman Sachs Ltd. from British Coal Corp. on July 22, 1996 for $65 million. | Finance |
3i Plc
3i Plc Financial ConglomeratesFinance 3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom. | Finance |
Parallel Private Equity LLP
Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | Finance |
| Bridgepoint Capital (GP) Ltd. |
- Stock Market
- Insiders
- Paul Whitney
